Literature DB >> 30244802

Overview of Studies Regarding Mesoporous Silica Nanomaterials and Their Biomedical Application.

Maria Vallet-Regi1, Fuyuhiko Tamanoi2.   

Abstract

Synthesis of mesoporous silica nanomaterials occurred in the late 1980s and early 1990s. Since then, we have seen dramatic increase in the number of publication dealing with this nanomaterial. In particular, there have been a large number of publications regarding biomedical application of mesoporous silica nanoparticles including their use in cancer therapy and diagnosis. Various surface modification strategies have been explored to enhance drug loading and to target them to tumor. In addition, the nanoparticles have been armed with controlled release capability. In this review, we point out some crucial issues regarding the material, which will be discussed in more detail in chapters of this volume.
© 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cancer therapy application; Mesoporous silica nanoparticles; Number of publication; Overview

Mesh:

Substances:

Year:  2018        PMID: 30244802     DOI: 10.1016/bs.enz.2018.07.001

Source DB:  PubMed          Journal:  Enzymes        ISSN: 1874-6047


  10 in total

Review 1.  Functionalization of Nanoparticulate Drug Delivery Systems and Its Influence in Cancer Therapy.

Authors:  Theodora Amanda Seidu; Perpetua Takunda Kutoka; Dorothy Owusu Asante; Muhammad Asim Farooq; Raphael N Alolga; Wang Bo
Journal:  Pharmaceutics       Date:  2022-05-23       Impact factor: 6.525

2.  Destruction of tumor mass by gadolinium-loaded nanoparticles irradiated with monochromatic X-rays: Implications for the Auger therapy.

Authors:  Kotaro Matsumoto; Hiroyuki Saitoh; Tan Le Hoang Doan; Ayumi Shiro; Keigo Nakai; Aoi Komatsu; Masahiko Tsujimoto; Ryo Yasuda; Tetsuya Kawachi; Toshiki Tajima; Fuyuhiko Tamanoi
Journal:  Sci Rep       Date:  2019-09-30       Impact factor: 4.379

Review 3.  Mesoporous Silica Platforms with Potential Applications in Release and Adsorption of Active Agents.

Authors:  Cristina Chircov; Angela Spoială; Cătălin Păun; Luminița Crăciun; Denisa Ficai; Anton Ficai; Ecaterina Andronescu; Ștefan Claudiu Turculeƫ
Journal:  Molecules       Date:  2020-08-21       Impact factor: 4.411

4.  Construction of Boronophenylalanine-Loaded Biodegradable Periodic Mesoporous Organosilica Nanoparticles for BNCT Cancer Therapy.

Authors:  Fuyuhiko Tamanoi; Shanmugavel Chinnathambi; Mathilde Laird; Aoi Komatsu; Albane Birault; Takushi Takata; Tan Le-Hoang Doan; Ngoc Xuan Dat Mai; Arthur Raitano; Kendall Morrison; Minoru Suzuki; Kotaro Matsumoto
Journal:  Int J Mol Sci       Date:  2021-02-24       Impact factor: 5.923

Review 5.  Understanding the mechanisms of silica nanoparticles for nanomedicine.

Authors:  Ziyuan Li; Yingwen Mu; Cheng Peng; Martin F Lavin; Hua Shao; Zhongjun Du
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2020-06-29

Review 6.  Recent Advances and Implication of Bioengineered Nanomaterials in Cancer Theranostics.

Authors:  Ayushi Rai; Saba Noor; Syed Ishraque Ahmad; Mohamed F Alajmi; Afzal Hussain; Hashim Abbas; Gulam Mustafa Hasan
Journal:  Medicina (Kaunas)       Date:  2021-01-21       Impact factor: 2.430

Review 7.  Development of Non-Porous Silica Nanoparticles towards Cancer Photo-Theranostics.

Authors:  Chihiro Mochizuki; Junna Nakamura; Michihiro Nakamura
Journal:  Biomedicines       Date:  2021-01-13

Review 8.  Novel Drug and Gene Delivery System and Imaging Agent Based on Marine Diatom Biosilica Nanoparticles.

Authors:  Hanaa Ali Hussein; Muhammad Shahid Nazir; Nizakat Azra; Zeenat Qamar; Azman Seeni; Tengku Ahmad Damitri Al-Astani Tengku Din; Mohd Azmuddin Abdullah
Journal:  Mar Drugs       Date:  2022-07-27       Impact factor: 6.085

9.  Molecular and Cellular Risk Assessment of Healthy Human Cells and Cancer Human Cells Exposed to Nanoparticles.

Authors:  Edward Helal-Neto; Aline Oliveira da Silva de Barros; Roberta Saldanha-Gama; Renata Brandão-Costa; Luciana Magalhães Rebêlo Alencar; Clenilton Costa Dos Santos; Ramón Martínez-Máñez; Eduardo Ricci-Junior; Frank Alexis; Verônica Morandi; Christina Barja-Fidalgo; Ralph Santos-Oliveira
Journal:  Int J Mol Sci       Date:  2019-12-28       Impact factor: 5.923

10.  Theranostic nanoplatform to target macrophages enables the inhibition of atherosclerosis progression and fluorescence imaging of plaque in ApoE(-/-) mice.

Authors:  Qi Wang; Yong Wang; Siwen Liu; Xuan Sha; Xiaoxi Song; Yue Dai; Mingming Zhao; Lulu Cai; Kai Xu; Jingjing Li
Journal:  J Nanobiotechnology       Date:  2021-07-28       Impact factor: 10.435

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.